CVS Health Ownership
| CVS Stock | USD 58.01 0.91 1.59% |
Shares in Circulation | First Issued 1985-09-30 | Previous Quarter 1.3 B | Current Value 1.3 B | Avarage Shares Outstanding 905.4 M | Quarterly Volatility 369.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
CVS |
CVS Stock Ownership Analysis
About 83.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.97. Some equities with similar Price to Book (P/B) outperform the market in the long run. CVS Health Corp has Price/Earnings To Growth (PEG) ratio of 2.2. The entity last dividend was issued on the 21st of October 2024. The firm had 2:1 split on the 7th of June 2005. CVS Health Corporation provides health services in the United States. CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. CVS Corp operates under Healthcare Plans classification in the United States and is traded on New York Stock Exchange. It employs 216000 people. For more info on CVS Health Corp please contact Karen Lynch at 401 765 1500 or go to https://www.cvshealth.com.Besides selling stocks to institutional investors, CVS Health also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different CVS Health's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align CVS Health's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
CVS Health Quarterly Liabilities And Stockholders Equity |
|
CVS Health Insider Trades History
Less than 1% of CVS Health Corp are currently held by insiders. Unlike CVS Health's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against CVS Health's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of CVS Health's insider trades
CVS Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as CVS Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading CVS Health Corp backward and forwards among themselves. CVS Health's institutional investor refers to the entity that pools money to purchase CVS Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Jpmorgan Chase & Co | 2024-06-30 | 13.9 M | Franklin Resources Inc | 2024-06-30 | 13.8 M | Pzena Investment Management, Llc | 2024-09-30 | 13.1 M | Charles Schwab Investment Management Inc | 2024-09-30 | 12.2 M | Amvescap Plc. | 2024-06-30 | 12.1 M | Glenview Capital Management Llc | 2024-09-30 | 11.9 M | Northern Trust Corp | 2024-09-30 | 11.6 M | Legal & General Group Plc | 2024-06-30 | 11.4 M | T. Rowe Price Associates, Inc. | 2024-06-30 | 10.2 M | Vanguard Group Inc | 2024-09-30 | 117.6 M | Blackrock Inc | 2024-06-30 | 100.2 M |
CVS Health Corp Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific CVS Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on CVS Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases CVS Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
CVS Health's latest congressional trading
Congressional trading in companies like CVS Health Corp, is subject to rigorous scrutiny to prevent conflicts of interest and insider trading. This is governed by multiple SEC regulations which were established to foster transparency and deter members of Congress from leveraging non-public information for personal gain. This oversight helps maintain public trust and ensures that investments in CVS Health by those in governmental positions are based on the same information available to the general public.
| 2024-11-13 | Representative Thomas Suozzi | Acquired Under $15K | Verify | ||
| 2024-10-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-09-12 | Senator Tommy Tuberville | Acquired Under $15K | Verify | ||
| 2024-07-22 | Representative Michael McCaul | Acquired Under $15K | Verify | ||
| 2024-07-08 | Representative Ro Khanna | Acquired Under $15K | Verify | ||
| 2024-07-06 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2024-05-22 | Representative William R Keating | Acquired Under $15K | Verify | ||
| 2024-01-17 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2024-01-16 | Senator Jerry Moran | Acquired Under $15K | Verify | ||
| 2023-10-20 | Senator Pete Ricketts | Acquired $50K to $100K | Verify | ||
| 2023-07-05 | Representative Dwight Evans | Acquired Under $15K | Verify | ||
| 2023-06-15 | Representative William R Keating | Acquired Under $15K | Verify | ||
| 2023-02-13 | Senator Dan Sullivan | Acquired Under $15K | Verify | ||
| 2022-01-01 | Representative Donald S Beyer Jr | Acquired Under $15K | Verify | ||
| 2021-11-18 | Representative Thomas Suozzi | Acquired $15K to $50K | Verify | ||
| 2021-03-30 | Representative Michael T McCaul | Acquired $100K to $250K | Verify | ||
| 2021-01-19 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2020-06-03 | Representative Earl Blumenauer | Acquired Under $15K | Verify | ||
| 2020-01-23 | Representative John Rutherford | Acquired Under $15K | Verify | ||
| 2020-01-20 | Representative Mo Brooks | Acquired Under $15K | Verify | ||
| 2019-12-12 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2019-08-15 | Senator John Hoeven | Acquired $50K to $100K | Verify | ||
| 2019-07-29 | Senator Thom Tillis | Acquired Under $15K | Verify | ||
| 2019-06-14 | Senator Thom Tillis | Acquired Under $15K | Verify | ||
| 2019-06-13 | Representative Bill Flores | Acquired Under $15K | Verify | ||
| 2019-06-11 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2019-06-10 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2019-05-08 | Representative Brian Mast | Acquired $50K to $100K | Verify | ||
| 2019-02-27 | Senator Thom Tillis | Acquired Under $15K | Verify | ||
| 2019-01-11 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2019-01-08 | Representative Steve Cohen | Acquired $15K to $50K | Verify | ||
| 2018-12-12 | Representative Robert J Wittman | Acquired Under $15K | Verify | ||
| 2018-05-10 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2018-05-09 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2017-11-08 | Senator James Inhofe | Acquired $50K to $100K | Verify | ||
| 2017-09-19 | Senator James Inhofe | Acquired $50K to $100K | Verify | ||
| 2017-06-06 | Senator Susan M Collins | Acquired $15K to $50K | Verify | ||
| 2017-06-05 | Senator Susan M Collins | Acquired $15K to $50K | Verify | ||
| 2016-12-16 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2016-12-15 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2016-11-08 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2016-11-07 | Senator Gary Peters | Acquired Under $15K | Verify | ||
| 2014-09-19 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2014-09-18 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2014-05-15 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify | ||
| 2014-05-14 | Senator Sheldon Whitehouse | Acquired Under $15K | Verify |
CVS Health Outstanding Bonds
CVS Health issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CVS Health Corp uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CVS bonds can be classified according to their maturity, which is the date when CVS Health Corp has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| CSLAU 495 27 APR 62 Corp BondUS12661PAF62 | View | |
| CSLAU 425 27 APR 32 Corp BondUS12661PAC32 | View | |
| CSLAU 405 27 APR 29 Corp BondUS12661PAB58 | View | |
| CSLAU 475 27 APR 52 Corp BondUS12661PAE97 | View | |
| CSLAU 4625 27 APR 42 Corp BondUS12661PAD15 | View | |
| CSLAU 385 27 APR 27 Corp BondUS12661PAA75 | View | |
| US12663QAC96 Corp BondUS12663QAC96 | View |
CVS Health Corporate Filings
8K | 18th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
F3 | 15th of November 2024 The report used by insiders such as officers, directors, and major shareholders (beneficial owners holding more than 10% of any class of the company's equity securities) to declare their ownership of a company's stock | ViewVerify |
13A | 13th of November 2024 The form used by investors holding more than 5% of a company's stock, to report their beneficial ownership pursuant to Rule 13d-1 or Rule 13d-2 under the Securities Exchange Act of 1934 | ViewVerify |
| 8th of November 2024 Other Reports | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CVS Stock Analysis
When running CVS Health's price analysis, check to measure CVS Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CVS Health is operating at the current time. Most of CVS Health's value examination focuses on studying past and present price action to predict the probability of CVS Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CVS Health's price. Additionally, you may evaluate how the addition of CVS Health to your portfolios can decrease your overall portfolio volatility.